128 related articles for article (PubMed ID: 38643755)
1. TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.
Liu G; Liu X; Zeng W; Zhou W
Pharmacology; 2024 Apr; ():1-14. PubMed ID: 38643755
[TBL] [Abstract][Full Text] [Related]
2. TFAP2A activates HMGA1 to promote glycolysis and lung adenocarcinoma progression.
Zhao J; Lan G
Pathol Res Pract; 2023 Sep; 249():154759. PubMed ID: 37586214
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factor FOXA1 Facilitates Glycolysis and Proliferation of Lung Adenocarcinoma via Activation of TEX19.
Zhang Y; Sheng H; Fu Y; Chen L
Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37606876
[TBL] [Abstract][Full Text] [Related]
4. HSPE1 enhances aerobic glycolysis to promote progression of lung adenocarcinoma.
Xie T; Li M
Mutat Res; 2024 Jun; 829():111867. PubMed ID: 38878504
[TBL] [Abstract][Full Text] [Related]
5. Serum Exosomes-Based Biomarker circ_0008928 Regulates Cisplatin Sensitivity, Tumor Progression, and Glycolysis Metabolism by miR-488/
Shi Q; Ji T; Ma Z; Tan Q; Liang J
Cancer Biother Radiopharm; 2023 Oct; 38(8):558-571. PubMed ID: 33661058
[No Abstract] [Full Text] [Related]
6. Prognostic and immunological values of SKA3 for overall survival in lung adenocarcinoma and its RNA binding protein involved mechanisms.
Gu Y; Li J; Guan H; Sun C
J Chemother; 2023 Dec; ():1-14. PubMed ID: 38146901
[TBL] [Abstract][Full Text] [Related]
7. FOXA1/UBE2T Inhibits CD8
Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
[TBL] [Abstract][Full Text] [Related]
8. LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis.
Li Z; Zhu T; Yao F; Shen X; Xu M; Fu L; Wu Y; Ding J; Zhang J; Zhao J; Dong L; Wang X; Yu G
J Bioenerg Biomembr; 2024 Apr; 56(2):181-191. PubMed ID: 38411863
[TBL] [Abstract][Full Text] [Related]
9. MiR-133b suppresses the proliferation, migration and invasion of lung adenocarcinoma cells by targeting SKA3.
Zhang M; Lan X; Chen Y
Cancer Biol Ther; 2021 Dec; 22(10-12):571-578. PubMed ID: 34711122
[TBL] [Abstract][Full Text] [Related]
10. HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma.
Ma Y; Ma X; Du B; Li X; Li Y
J Cancer; 2024; 15(10):2913-2927. PubMed ID: 38706894
[No Abstract] [Full Text] [Related]
11. NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis.
Zhang Z; Qi D; Liu X; Kang P
Clin Respir J; 2023 Sep; 17(9):884-892. PubMed ID: 37553792
[TBL] [Abstract][Full Text] [Related]
12. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma.
Ai C; Huang Z; Rong T; Shen W; Yang F; Li Q; Bi L; Li W
Electrophoresis; 2024 Apr; ():. PubMed ID: 38629299
[TBL] [Abstract][Full Text] [Related]
13. FOXP3 targets KIF5A to increase lactate production and promote docetaxel resistance in lung adenocarcinoma.
Dong L; Feng C; Cheng W; Huang A; Ying K
Acta Biochim Biophys Sin (Shanghai); 2024 May; ():. PubMed ID: 38798241
[TBL] [Abstract][Full Text] [Related]
14. The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
Chen W; Li X; Du B; Cui Y; Ma Y; Li Y
Cancer Med; 2023 Feb; 12(4):4421-4433. PubMed ID: 35924724
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract][Full Text] [Related]
16. ANKRD22 promotes M2 polarization in lung adenocarcinoma macrophages via the glycolytic pathway.
Cao J; Zhang H; Wei X; Zhou H
Chem Biol Drug Des; 2024 Jan; 103(1):e14445. PubMed ID: 38230786
[TBL] [Abstract][Full Text] [Related]
17. The E2F1/MELTF axis fosters the progression of lung adenocarcinoma by regulating the Notch signaling pathway.
Zhang L; Shi L
Mutat Res; 2023; 827():111837. PubMed ID: 37820570
[TBL] [Abstract][Full Text] [Related]
18. Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma.
Lin Y; An J; Zhuo X; Qiu Y; Xie W; Yao W; Yin D; Wu L; Lei D; Li C; Xie Y; Hu A; Li S
Int J Gen Med; 2022; 15():4635-4647. PubMed ID: 35535142
[TBL] [Abstract][Full Text] [Related]
19. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
20. The comprehensive investigation of transcription factor AP-2 alpha in lung adenocarcinoma.
Liao H; Lin P
Transl Cancer Res; 2020 Mar; 9(3):1547-1557. PubMed ID: 35117502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
